A year into the pandemic, early data and surveys point to a baby bust in many advanced economies from the U.S. to Europe to East Asia, often on top of existing downward trends in births.
Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech shares Phase 3 Interim Results of COVAXIN, Demonstrates Efficacy of 81% GlobeNewswireCriticized Indian Vaccine Already in Use Found 81% Effective BloombergBharat Biotech’s COVID-19 shot 81% effective, Indian firm’s interim data shows Yahoo NewsOpinion | Covid vaccination: How Modi inspired India TV NewsBharat Biotech’s Covaxin Shows 81% Efficacy In Phase 3 Trials Conducted…
Researchers and doctors are sounding the alarm over the new coronavirus strain known as P.1, which a report released on Tuesday said is 1.4 to 2.2 times more contagious than variants seen previously in Brazil.
Why the J&J Covid Vaccine Could Protect Millions (Podcast)
Several COVID-19 variants have been detected across the U.S., and some have the ability to spread faster than others.
One dose reduced the risk of hospitalization among people over 70 years old by 80% compared with those of a similar age who weren’t vaccinated, according to new real-world data from Britain.
Dr. Paloma Marin-Nevarez graduated from medical school during the pandemic. We follow the rookie doctor for her first months working at a hospital in Fresno, California, as she grapples with isolation, anti-mask rallies and an overwhelming number of deaths.
Random variation is an essential component of all living things. It drives diversity, and it is why there are so many different species. Viruses are no exception. Most viruses are experts at changing genomes to adapt to their environment. We now have evidence that the virus that causes Covid, SARS-CoV-2, not only changes but changes…
Why is it so hard to picture COVID-19?
Several proposals have emerged on how to distribute the COVID-19 vaccine, but they fall short in ensuring that the vaccine is distributed fairly. A team including Binghamton University professor Nicole Hassoun suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible.